LEPTOMENINGEAL METASTASIS
Clinical trials for LEPTOMENINGEAL METASTASIS explained in plain language.
Never miss a new study
Get alerted when new LEPTOMENINGEAL METASTASIS trials appear
Sign up with your email to follow new studies for LEPTOMENINGEAL METASTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New dosing strategy aims to fight lung Cancer's spread to the brain
Disease control Not yet recruitingThis study is testing if taking a higher dose of the lung cancer drug furmonertinib every other day is more effective and safe for patients whose cancer has spread to the lining of the brain and spinal cord. It will enroll 42 adults with a specific genetic mutation (EGFR) whose c…
Matched conditions: LEPTOMENINGEAL METASTASIS
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New vaccine trial targets cancer that spreads to the brain
Disease control Not yet recruitingThis early-stage study is testing whether a new vaccine, combined with an existing immunotherapy drug, is safe and practical for patients whose cancer has spread to the brain or spinal fluid. It will involve about 20 patients whose cancer has worsened despite standard treatments.…
Matched conditions: LEPTOMENINGEAL METASTASIS
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug trial targets advanced breast cancer in the brain
Disease control Not yet recruitingThis study is testing an investigational drug called SHR-A1811 for women with advanced HER2-positive breast cancer that has spread to the brain. It aims to see if the drug is safe and effective at controlling the cancer in the brain and spinal fluid. The trial will include two gr…
Matched conditions: LEPTOMENINGEAL METASTASIS
Phase: PHASE1, PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC